Technical Analysis for AMED - Amedisys Inc

Grade Last Price % Change Price Change
grade A 87.93 0.21% 0.18
AMED closed up 0.21 percent on Thursday, June 21, 2018, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical AMED trend table...

Date Alert Name Type % Chg
Jun 21 New 52 Week Closing High Bullish 0.00%
Jun 21 NR7 Range Contraction 0.00%
Jun 21 New 52 Week High Strength 0.00%
Jun 21 Overbought Stochastic Strength 0.00%
Jun 21 Up 3 Days in a Row Strength 0.00%
Jun 21 Up 4 Days in a Row Strength 0.00%
Jun 20 New 52 Week Closing High Bullish 0.21%
Jun 20 New 52 Week High Strength 0.21%
Jun 20 Overbought Stochastic Strength 0.21%
Jun 20 Up 3 Days in a Row Strength 0.21%

Older signals for AMED ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Amedisys, Inc., together with its subsidiaries, operates as a home health and hospice company. It operates in two segments, Home Health and Hospice. The Home Health segment offers a range of services in the homes of individuals who may be recovering from an illness, injury, or surgical procedure. This segment provides skilled nursing, home health aides, physical and occupational therapy, speech therapy, and medical social services; and chronic care clinical programs for patients with chronic diseases, such as cardiovascular, respiratory, diabetes, behavioral health, rehabilitative, and medical surgical conditions. The Hospice segment offers care that is designed to offer comfort and support for those who are facing a terminal illness, including heart disease, pulmonary disease, dementia, Alzheimer's, HIV/AIDS, or cancer. As of December 31, 2012, the company owned and operated 435 Medicare-certified home health care centers, 97 Medicare-certified hospice care centers, and 2 hospice inpatient units in 38 states within the United States, the District of Columbia, and Puerto Rico. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.
Is AMED a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 88.49
52 Week Low 45.6
Average Volume 238,020
200-Day Moving Average 59.6219
50-Day Moving Average 73.4618
20-Day Moving Average 80.517
10-Day Moving Average 83.921
Average True Range 2.1081
ADX 50.24
+DI 40.72
-DI 8.3
Chandelier Exit (Long, 3 ATRs ) 82.1657
Chandelier Exit (Short, 3 ATRs ) 78.0643
Upper Bollinger Band 88.9101
Lower Bollinger Band 72.1239
Percent B (%b) 0.94
BandWidth 20.84802
MACD Line 3.9584
MACD Signal Line 3.4929
MACD Histogram 0.4656
Fundamentals Value
Market Cap 2.97 Billion
Num Shares 33.8 Million
EPS 1.17
Price-to-Earnings (P/E) Ratio 75.15
Price-to-Sales 1.15
Price-to-Book 3.39
PEG Ratio 1.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 89.70
Resistance 3 (R3) 89.69 89.09 89.41
Resistance 2 (R2) 89.09 88.64 89.10 89.31
Resistance 1 (R1) 88.51 88.36 88.21 88.52 89.21
Pivot Point 87.91 87.91 87.76 87.92 87.91
Support 1 (S1) 87.33 87.46 87.03 87.34 86.65
Support 2 (S2) 86.73 87.18 86.74 86.55
Support 3 (S3) 86.15 86.73 86.46
Support 4 (S4) 86.16